Impairment in emotion perception from body movements in individuals with bipolar I and bipolar II disorder is associated with functional capacity

被引：0
作者：
Anja Vaskinn
Trine Vik Lagerberg
Thomas D. Bjella
Carmen Simonsen
Ole A. Andreassen
Torill Ueland
Kjetil Sundet
机构：
[1] University of Oslo,Department of Psychology
[2] Oslo University Hospital,NORMENT KG Jebsen Centre for Psychosis Research
[3] Oslo University Hospital,Early Intervention in Psychosis Advisory Unit
[4] University of Oslo,Department of Mental Health and Addiction, Institute of Clinical Medicine
来源：
International Journal of Bipolar Disorders | / 5卷
关键词：
Bipolar disorder; Social cognition; Emotion perception; Body language; Cognition; Psychosis; Functioning; Functional capacity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   Metabolic Profile of Lumateperone in Late-Phase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder [J].
Mates, Sharon ;
Durgam, Suresh ;
Kozauer, Susan G. ;
Huo, Jason ;
Davis, Robert E. ;
Correll, Christoph U. .
NEUROPSYCHOPHARMACOLOGY, 2022, 47 :195-195
[32]   Metabolic Profile of Lumateperone in Late-Phase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder [J].
Mates, Sharon ;
Durgam, Suresh ;
Kozauer, Susan G. ;
Huo, Jason ;
Davis, Robert E. ;
Correll, Christoph U. .
NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) :195-195
[33]   Sources of Heterogeneity of Bipolar Disorder: Multidomain Discrimination of Bipolar-I From Bipolar-II Subtypes in the NIMH Family Study of Affective and Anxiety Spectrum Disorders [J].
Marangoni, Ciro ;
Cui, Lihong ;
Merikangas, Kathleen .
NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) :81-81
[34]   Conversion from bipolar disorder not otherwise specified (BP-NOS) to bipolar I or II in youth with family history as a predictor of conversion [J].
Martinez, Molly S. ;
Fristad, Mary A. .
JOURNAL OF AFFECTIVE DISORDERS, 2013, 148 (2-3) :431-434
[35]   Limbic and cortical regions as functional biomarkers associated with emotion regulation in bipolar disorder: A meta-analysis of neuroimaging studies [J].
Ahmed, Yaman B. ;
Al-Bzour, Ayah N. ;
Alzghoul, Saja M. ;
Ibrahim, Ruaa B. ;
Al-Khalili, Anas A. ;
Al-Majali, Ghayda'a N. ;
Hamza, Ammar I. ;
Al-Zamer, Yazan S. ;
Alhayek, Kefah ;
Kofahi, Raed ;
Leffler, Alexandra ;
El Salem, Khalid ;
Al Qawasmeh, Majdi .
JOURNAL OF AFFECTIVE DISORDERS, 2023, 323 :506-513
[36]   Emotion Recognition in the Real World: Passively Collecting and Estimating Emotions From Natural Speech Data of Individuals With Bipolar Disorder [J].
Provost, Emily Mower ;
Sperry, Sarah H. ;
Tavernor, James ;
Anderau, Steve ;
Yocum, Anastasia ;
McInnis, Melvin G. .
IEEE TRANSACTIONS ON AFFECTIVE COMPUTING, 2025, 16 (01) :28-40
[37]   Evaluating lumateperone for its use in treating depressive episodes associated with bipolar I or II disorder in adults [J].
Abuelazm, Hagar ;
Elsayed, Omar H. H. ;
El-Mallakh, Rif S. S. .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, 23 (08) :751-756
[38]   Similarities of Aspects of Biological Rhythms between Major Depression and Bipolar II Disorder Compared to Bipolar I Disorder: A Finding from the Early-Onset Mood Disorder Cohort [J].
Kim, Su Cheol ;
Cho, Chul-Hyun ;
Lee, Yujin ;
Seo, Ju Yeon ;
Ahn, Yong-Min ;
Kim, Se Joo ;
Ha, Tae Hyon ;
Cha, Boseok ;
Moon, Eunsoo ;
Park, Dong Yeon ;
Baek, Ji Hyun ;
Kang, Hee-Ju ;
An, Hyonggin ;
Lee, Heon-Jeong .
PSYCHIATRY INVESTIGATION, 2019, 16 (11) :829-835
[39]   Evaluation of Mania and Hypomania in Late-Phase Clinical Trials of Lumateperone in the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder [J].
Tohen, Mauricio ;
Kozauer, Susan G. ;
Mo, Yifan ;
Earley, Willie R. ;
Durgam, Suresh .
NEUROPSYCHOPHARMACOLOGY, 2022, 47 :198-199
[40]   Evaluation of Mania and Hypomania in Late-Phase Clinical Trials of Lumateperone in the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder [J].
Tohen, Mauricio ;
Kozauer, Susan G. ;
Mo, Yifan ;
Earley, Willie R. ;
Durgam, Suresh .
NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) :198-199
12345